Want to join the conversation?
In 3Q16, $ISRG's US procedures grew approx. 11% and outside of the US, procedures grew approx. 25%. In the United States, combined growth in mature procedures slowed in 3Q16. General and thoracic procedure growth remained healthy. In US gynaecology, procedures in 3Q16 grew modestly YoverY.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.